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A B S T R A C T
Background
Postoperative nausea and vomiting is a common and unpleasant phenomenon and current therapies are not always effective for all
patients. Aromatherapy has been suggested as a possible addition to the available treatment strategies.
Objectives
This review sought to establish what effect the use of aromatherapy has on the severity and duration of established postoperative nausea
and vomiting and whether aromatherapy can be used with safety and clinical effectiveness comparable to standard pharmacological
treatments.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 3); MEDLINE;
EMBASE; CINAHL; CAM on PubMed; Meditext; LILACS; and ISI Web of Science as well as grey literature sources and the reference
lists of retrieved articles. We conducted database searches up to August 2011.
Selection criteria
We included all randomized controlled trials (RCTs) and controlled clinical trials (CCTs) where aromatherapy was used to treat
postoperative nausea and vomiting. Interventions were all types of aromatherapy. Aromatherapy was defined as the inhalation of the
vapours of any substance for the purposes of a therapeutic benefit. Primary outcomes were the severity and duration of postoperative
nausea and vomiting. Secondary outcomes were adverse reactions, use of rescue anti-emetics and patient satisfaction with treatment.
Data collection and analysis
Two review authors assessed risk of bias in the included studies and extracted data. As all outcomes analysed were dichotomous, we
used a fixed-effect model and calculated relative risk (RR) with associated 95% confidence interval (95% CI).
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Main results
The nine included studies comprised six RCTs and three CCTs with a total of 402 participants. The mean age and range data for all
participants were not reported for all studies. The method of randomization in four of the six included RCTs was explicitly stated and
was adequate. Incomplete reporting of data affected the completeness of the analysis. Compared with placebo, isopropyl alcohol vapour
inhalation was effective in reducing the proportion of participants requiring rescue anti-emetics (RR 0.30, 95% CI 0.09 to 1.00, P
= 0.05). However, compared with standard anti-emetic treatment, isopropyl alcohol was not effective in reducing the proportion of
participants requiring rescue anti-emetics (RR 0.66, 95% CI 0.39 to 1.13, P = 0.13) except when the data from a possibly confounded
study were included (RR 0.66, 95% CI 0.45 to 0.98, P = 0.04). Where studies reported data on patient satisfaction with aromatherapy,
there were no statistically significant differences between the groups (RR 1.12, 95% CI 0.62 to 2.03, P = 0.71).
Authors’ conclusions
Isopropyl alcohol was more effective than saline placebo for reducing postoperative nausea and vomiting but less effective than standard
anti-emetic drugs. There is currently no reliable evidence for the use of peppermint oil.
P L A I N L A N G U A G E S U M M A R Y
Aromatherapy for treating postoperative nausea and vomiting
Postoperative nausea and vomiting (PONV) is a common and unpleasant side effect of surgery, with 20% to 30% of all patients
suffering moderate to severe nausea and vomiting following general anaesthesia using volatile agents (inhaled anaesthesia). Nausea is
an abdominal discomfort or queasiness that may be accompanied by vomiting (the forceful expulsion of stomach contents through
the mouth). Current drug treatments may not always work effectively or they may have unpleasant adverse effects. Aromatherapy
is sometimes recommended for treating nausea and vomiting, though currently there is not sufficient evidence that it is effective.
Aromatherapy uses inhalation of the vapour of essential oils or other substances to treat or alleviate physical and emotional symptoms.
We examined nine studies of aromatherapy for PONV, with a total of 402 participants. Six studies of the brief inhalation of isopropyl
alcohol vapours showed that it can have some effect in reducing postoperative nausea and vomiting; however it seems to be less effective
than standard drug treatments. There was a moderate risk of bias due to the design of some of the studies. Isopropyl alcohol is also
known as rubbing alcohol and is commonly found in the type of ’prep-pad’ used to clean skin prior to injection. There is currently
no reliable evidence to support the use of other aromatherapies such as peppermint oil to treat postoperative nausea and vomiting. No
included studies reported any adverse effects from the aromatherapies used.
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B A C K G R O U N D
Aromatherapy has been recommended for the treatment of post-
operative nausea and vomiting (PONV) (Bone 1990; Maddocks-
Jennings 2004). It is known that this therapy is inexpensive,
non-invasive and generally has low levels of adverse effects (Price
2007), particularly in comparison to standard pharmacological
treatments.What is not known is whether the clinical effectiveness
justifies its use.
Nausea is an abdominal discomfort or queasiness that may be ac-
companied by vomiting (the forceful expulsion of stomach con-
tents through the mouth). Postoperative nausea and vomiting
(PONV) is one of the most common adverse reactions to surgery
and all types of anaesthesia, with 20% to 30% of all patients suf-
fering moderate to severe nausea and vomiting following general
anaesthesia using volatile agents (Watcha 1992).
Aside from the distressing nature of PONV itself, as a result of
PONV patients may experience such adverse effects as wound de-
hiscence, dehydration, electrolyte imbalances or aspiration pneu-
monia (Kovac 2000). Other adverse effects may include increased
patient bed days, unplanned readmissions (particularly in the case
of day surgery) (Kovac 2000) and decreased patient satisfaction
(Myles 2000). Certain patients are more pre-disposed than others
to suffering from PONV and risk factors include being female,
a non-smoker, having a history of PONV or perioperative opi-
oid exposure (Koivuranta 1997). Along with postoperative pain,
PONV is one of the main concerns of patients facing surgery and
one of the main causes of patient dissatisfaction (Myles 2000).
Current treatment involves either the prophylactic or symptomatic
administration of anti-emetic drugs such as droperidol, meto-
clopramide or 5-HT3 receptor antagonists such as ondansetron
(White 1999). Despite a wide range of available treatments, some
patients will still experience PONV in varying levels of severity
(Kazemi-Kjellberg 2001). Clinically, the severity of PONV is gen-
erally measured by means of a visual analogue scale (VAS), which
provides a visual representation of the patient’s condition over a
numerical range (for example 0 to 5), or verbal descriptive scales
(for example no nausea, some nausea, very nauseated, retching,
vomiting) (Boogaerts 2000). The effectiveness of the various drugs
for PONV has already been the subject of a Cochrane review
(Carlisle 2006), however no existing review has examined the ef-
fectiveness of aromatherapy to treat this condition.
The use of aromatherapy oils is recognized as an effective treatment
for nausea in general (Chiravalle 2005; Mamaril 2006; Merritt
2002; Tate 1997). Aromatherapy uses the application of essential
oils or other substances to any part of the body for the purpose of
inhalation of the vapours or absorption of the oil into the skin to
treat or alleviate physical and emotional symptoms (Price 2007).
Essential oils can be absorbed through the skin and may exert a
physiological effect on cellular and organ function, although this
is not clinically understood (Ernst 2001). Aromatherapy is well
accepted by many health consumers, who find it more pleasant
and acceptable than the ingestion or injection of conventional
drugs (Eisenberg 1998). A significant number of health consumers
already self-prescribe and administer aromatherapy products for
various common conditions, or consult qualified or unqualified
aromatherapy practitioners for health advice (Eisenberg 1998).
In particular, ginger, fennel and peppermint, as either a topical
application (massage or a compress) or via inhalation, are well-
known treatments (Price 2007). The effectiveness of the oils may
be due to analgesic and anti-emetic properties (with peppermint
oil and ginger oil) or anti-spasmodic properties (peppermint oil
and fennel oil). Peppermint oil is well recognized for its role in
digestion disorders, due principally to the presence of menthols
(see Appendix 1 for details). There have been a number of studies
conducted using ginger oil, with conflicting results (Arfeen 1995;
Bone 1990; Meyer 1995; Phillips 1993). Isopropyl alcohol is said
to be a traditional nausea remedy from South America (Anderson
2004; Mamaril 2006; Spencer 2004), however none of the pa-
pers citing this provided a primary source for this information.
Isopropyl alcohol, also known as rubbing alcohol and commonly
found in the type of ’prep-pad’ used to clean skin prior to injec-
tion, does appear to be widely used in some postanaesthesia care
units to treat PONV (Cotton 2007;Merritt 2002; Pellegrini 2009;
Spencer 2004; Wang 1999; Winston 2003). It is the subject of
several effectiveness studies.
O B J E C T I V E S
To establish:
• what effect the use of aromatherapy has on the severity of
established postoperative nausea and vomiting;
• what effect the use of aromatherapy has on the duration of
established postoperative nausea and vomiting;
• whether aromatherapy can be used with safety and clinical
effectiveness comparable to standard pharmacological treatments
to treat established postoperative nausea and vomiting.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered any randomized controlled trials (RCTs) or con-
trolled clinical trials (CCTs) that evaluated the effect of aromather-
apy on established PONV. In order to obtain the widest range of
studies we set no date of publication or language limits.
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Types of participants
We considered all studies that included patients (both adult and
paediatric, paediatric being children aged less than 18 years of age)
having any type of surgical procedure under general anaesthesia,
regional anaesthesia or sedation, either as hospital inpatients or in
day or ambulatory facilities, who were given aromatherapy treat-
ments for management of existing PONV. For the purposes of this
review we considered postoperative to be the period from day of
surgery to discharge from hospital or, in the case of day hospital
patients, up to the fifth postdischarge day.
We excluded studies of non-surgical patients (medical, oncology).
We also excluded studies in which aromatherapy was used solely
to prevent postoperative nausea and vomiting.
Types of interventions
Interventions of interest were those where aromatherapy prod-
ucts were used by any delivery method (for example direct inhala-
tion, diffusion, massage or compress) to treat symptoms of estab-
lished postoperative nausea and vomiting, either in comparison
to a placebo or compared with standard anti-emetic treatments.
Aromatherapy was defined as the inhalation of the vapours of any
substance for the purposes of a therapeutic benefit.
Types of outcome measures
Primary outcomes
• Severity of nausea or vomiting, or both, post-initiation of
treatment as measured by a validated scale or medical or nursing
observation
• Duration of nausea or vomiting, or both, post-initiation of
treatment as measured by patient report or medical or nursing
observation
Secondary outcomes
• Use of pharmacological anti-emetics
• Any adverse reactions or events (common reactions to
aromatherapy include skin rashes, dyspnoea, headache, cardiac
arrhythmias, hypotension, hypertension or dizziness (Price
2007))
• Patient satisfaction with treatment as measured by a
validated scale
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2011, Issue 3); MEDLINE
(via Ovid) (1966 to 2 August 2011); EMBASE (1966 to 2 August
2011); CINAHL (EBSCOhost) (1982 to 2 August 2011); CAM
on PubMed (1966 to 2 August 2011); Meditext (1995 to 2 August
2011); LILACS (1982 to 2 August 2011); ISI Web of Science
(1985 to 2 August 2011).
We developed a specific strategy for each database. We based each
search strategy on that developed for MEDLINE (see Appendix
2 for details). We combined the MEDLINE search strategy with
the Cochrane highly sensitive search strategy, phases one and two,
as contained in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011).
Searching other resources
We also identified trials by manually searching abstracts of rele-
vant conference proceedings such as the National Association for
Holistic Aromatherapy Conference.
We checked the reference lists of relevant articles and attempted to
contact relevant trial authors to identify any additional or ongoing
studies.
We also searched for relevant trials on specific sites:
1. Current Controlled Trials at http://www.controlled-
trials.com;
2. Clinical Study Results at http://
www.clinicalstudyresults.org;
3. SIGLE at http://opensigle.inist.fr/ (grey literature);
4. New York Library of Medicine Grey Literature Report at
http://www.nyam.org/library/pages/grey_literature_report (grey
literature);
5. National Institute of Clinical Studies at http://
www.nhmrc.gov.au/nics/index.htm;
6. Science.gov at http://www.science.gov/browse/w_127.htm
(grey literature).
We did not apply language or publication date restrictions.
Data collection and analysis
Selection of studies
Two authors (SH and ES) independently scanned the titles and
abstracts of reports identified by the described variety of search
strategies. We retrieved and evaluated potentially relevant studies,
chosen by at least one author, in full-text versions. We retrieved
and translated any articles which appeared relevant but were not
published in full in English. Two authors (SH and ES) indepen-
dently assessed the congruence of trials with the review’s inclusion
criteria using a checklist that was designed in advance for that pur-
pose (Appendix 3). The third author (AC) settled any disagree-
ments.
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Data extraction and management
Two authors (SH and ES) independently extracted data using a
tool developed and piloted by the authors (Appendix 4). We re-
solved any disagreements through consultation with the third au-
thor (AC).
Assessment of risk of bias in included studies
We assessed the risk of bias using the tool provided in the RevMan
5.1 software, based on the work of The Cochrane Collaboration
(Higgins 2011). Any disagreements were adjudicated by the third
author (AC).Weused the followingfive criteria to assess risk of bias
for each individual study: random sequence generation, allocation
concealment, blinding, incomplete outcome data, and selective
reporting.
Measures of treatment effect
Because of the subjective nature of nausea, measures of treatment
effect were largely limited to patient-reported effects, measured by
various scales including visual analogue scales (VAS), verbal nu-
merical rating scales (VRNS) and descriptive ordinal scales (DOS).
We included other measures of effect, such as number of vomiting
episodes or retching, and the use of pharmacological ’rescue’ anti-
emetics. All outcome measures that were evaluated were dichoto-
mous and, as such, we used relative risk (RR) with 95% confidence
interval (95% CI) to measure treatment effect.
Unit of analysis issues
For cross-over trials, a paired t-test was to be used to analyse par-
ticipant data had sufficient data been available. Had cluster ran-
domized trials been included, effect estimates and standard errors
would have been meta-analysed using the generic inverse-variance
method in RevMan.
Dealing with missing data
Where necessary, we contacted authors of included studies regard-
ing missing study information. We were able to contact some au-
thors to retrieve missing data, such as details about randomization,
statistical detail and standard deviations, however others did not
reply or were not contactable. Where data were found to be miss-
ing and the authors were not contactable, where possible we cal-
culated missing statistics (such as standard deviations) from other
quoted statistics (such as standard errors or CIs). If missing data
remained then we performed an available case analysis, excluding
data where outcome information was unavailable.
Assessment of heterogeneity
We assessed statistical heterogeneity through the use of the Chi2
test, as well as by reviewing the I2 statistic. If either the Chi2 test
resulted in a P value less than 0.10 or the I2 statistic was greater
than 40%, further investigation of the reasons for heterogeneity
was carried out. Clinically diverse studies were analysed separately
wherever appropriate.
Assessment of reporting biases
Due to the small number of studies included in this review, and
the small number that could be included in the meta-analyses,
we considered it inappropriate to generate funnel plots to assess
reporting biases (Egger 1997). We did consider studies from a
wide range of locations, languages and publications, which we
believe has reduced the likelihood of reporting biases affecting our
findings (Higgins 2011).
Data synthesis
We entered all trials included in the systematic review into Re-
view Manager (RevMan 5.1) and combined data quantitatively,
where possible. We presented the main outcomes in this review
as dichotomous variables. We calculated pooled estimates using
the fixed-effect model with the Mantel-Haenszel method as the
studies were homogenous and small numbers of events were ob-
served. We determined the levels of heterogeneity by the I2 statis-
tic (Higgins 2011). We used a random-effects model when the I2
was more than 50%.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were conducted where data were available, as
described by Deeks et al (Deeks 2001) and as recommended in
Section 8.8 of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). We planned to compare:
• adults and children;
• different types of surgery (e.g. orthopaedic and
gynaecologic surgery);
• types of aromatherapy delivery methods (e.g. inhalation,
massage, ingestion);
• trial quality (e.g. RCT, CCT).
Due to the limited data available, we were unable to perform any
subgroup analyses.
Sensitivity analysis
Because of considerable concern about the risk of bias due to
confounding in Merritt 2002 we performed a sensitivity analysis
and have reported findings both with and without the results of
this study.
R E S U L T S
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Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The studies were randomized controlled trials (RCTs) or con-
trolled clinical trials (CCTs) conducted on postoperative adult
and paediatric patients in postanaesthesia care units (PACU) and
same-day surgery units (SDSU). The intervention groups were
given aromatherapy treatments to treat complaints of postopera-
tive nausea and vomiting. The control groups were treated with
either a saline placebo or standard anti-emetic drugs.
Results of the search
We conducted searches in a wide range of databases and
sources: MEDLINE; CAM on PubMed; CENTRAL; EMBASE;
CINAHL; Meditext; LILACS; Web of Science; Current Con-
trolled Trials; Clinical Study Results; SIGLE; New York Library
of Medicine Grey Literature Report; National Institute of Clinical
Studies; Google Scholar (English, German, Spanish); Science.gov
(grey literature); Conference Proceedings of the National Associ-
ation for Holistic Aromatherapy; and reference lists.
Of the 1386 articles we identified, 44 were deemed relevant
enough to be retrieved for further evaluation. After appraisal of
the full version of each study, nine studies were found to meet the
criteria for inclusion in the review. For further details see Figure 1.
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Figure 1. Results of searches
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Included studies
We included nine studies, comprised of six RCTs (Anderson 2004;
Cotton 2007; Kamalipour 2002; Pellegrini 2009; Wang 1999;
Winston 2003) and three CCTs (Langevin 1997; Merritt 2002;
Tate 1997) with a total of 402 participants. The mean age and
range data for all participants were not available for all studies. See
Characteristics of included studies for further details.
Excluded studies
We excluded 35 studies for not meeting the inclusion criteria, ei-
ther by study design (notRCTorCCT) or by study outcomes (pre-
vention of PONV not treatment). See Characteristics of excluded
studies for details.
Risk of bias in included studies
We assessed the risk of bias in terms of allocation sequence gener-
ation, blinding, incomplete reporting of outcome data, and selec-
tive reporting. Risk of bias was found to bemoderate to high across
all included studies. For details of the risk of bias assessment, see
Figure 2 and Figure 3.
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Methods of allocation varied across the included studies. In
four studies the method of randomization was explicitly stated:
Wang 1999 utilized a ’random number table’; Cotton 2007 and
Pellegrini 2009 utilized a ’computer generated random numbers
table’; and Anderson 2004 used a ’random number generator’. For
Kamalipour 2002 the treatment and control groups were “ran-
domly selected” but the authors did not state what method of
randomization was used. Similarly, in Winston 2003 participants
were “randomly assigned” to receive either the treatment or control
but themethod of sequence generationwas not stated. In Langevin
1997, which used a cross-over clinical trial design, the test agents
were administered in a “random sequence” but again the method
of randomization was not stated. The study byMerritt 2002 was a
CCT and participants were not randomly allocated, rather assign-
ment to the treatment and control groups was alternated by day.
The participants in Tate 1997 were “randomly allocated” to wards
which had been assigned to the separate treatments, the control
and placebo arms of the study.
Allocation concealment appeared tohave beenundertaken for four
studies (Anderson 2004; Cotton 2007; Pellegrini 2009; Winston
2003). The remaining five studies did not report data on whether
allocation was concealed.
Blinding
Five included studies (Anderson 2004; Langevin 1997; Merritt
2002;Tate 1997;Wang 1999) appeared tohave undertaken at least
some blinding of participants and assessors; published details were
unclear for two (Kamalipour 2002; Pellegrini 2009) and for two
studies (Cotton 2007; Winston 2003) blinding was explicitly not
done. Three included studies (Anderson 2004; Langevin 1997;
Wang 1999) explicitly blinded assessors.
Incomplete outcome data
Data appeared to have been reported for all participants and out-
comes in seven studies (Anderson 2004;Cotton 2007;Kamalipour
2002; Pellegrini 2009; Tate 1997; Wang 1999; Winston 2003),
however it was unclear whether this had occurred in the remaining
two studies (Langevin 1997; Merritt 2002).
Selective reporting
For seven studies (Anderson 2004; Cotton 2007; Kamalipour
2002; Langevin 1997;Merritt 2002; Pellegrini 2009;Wang 1999)
it was unclear whether there was any degree of selective reporting,
and for two studies it appeared that a degree of selective reporting
had taken place (Tate 1997; Winston 2003).
Other potential sources of bias
Other potential sources of bias were evident in two studies. Due
to the design of the study by Tate 1997, it was possible there was
some demand characteristic effect (an effect where participants
interpret the purpose of the study and modify their behaviour or
reporting accordingly (Orne 1962)) on patient self-reporting of
results. The authors of Merritt 2002 reported that their study was
probably confounded by the aggressive preoperative anti-emetic
prophylaxis given to 104 out of the 111 participants enrolled into
the study. Four studies appeared free of other potential sources
of bias (Cotton 2007; Pellegrini 2009; Wang 1999; Winston
2003). It was unclear from the minimal data reported in Langevin
1997 andKamalipour 2002whether therewere any other potential
sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Isopropyl
alcohol compared to standard treatment for treatment of
postoperative nausea and vomiting; Summary of findings
2 Isopropyl alcohol compared to saline for treatment of
postoperative nausea and vomiting
Seven studies examined the effectiveness of isopropyl alcohol (IPA)
as an anti-emetic and two studies investigated the effectiveness
of peppermint oil (one study trialled both interventions). All in-
cluded studies measured nausea as a chief outcome. Five studies
also reported data on the number of participants requiring rescue
anti-emetics for unresolved nausea. All analyses resulted in signif-
icance values for heterogeneity testing of greater than 0.10 and I2
values less than 40%, indicating that statistical heterogeneity was
not present.
Primary outcome: severity and duration of nausea
The only studies able to be compared for this outcome, with com-
patible drug administration times, were the Langevin 1997 and
Kamalipour 2002 studies. However, the primary outcome analysis
could not be performed on these two studies. The only measure
of nausea for the Kamalipour study was percentage of patients
who responded to the treatment, and this measure could not be
compared with the Langevin study as there was ambiguity in the
paper’s definition of response.
The Anderson 2004 study could not be compared with the
Langevin and Kamalipour studies for this outcome as the times
for drug administration were: reporting nausea, two minutes later,
then three minutes later; which is different to the drug adminis-
tration times for the two other studies.
The two studies examining isopropyl alcohol versus standard drug
treatment also could not be compared as the number of applica-
tions of isopropyl alcohol differed between the studies. For the
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Cotton 2007 study, the maximum number of isopropyl alcohol
applications was three whereas for the Winston 2003 study the
maximum number of applications was two.
Finally, the two studies which looked at peppermint aromather-
apy (Anderson 2004; Tate 1997) could not be compared due to
differing drug administration times and units of measurement.
The single paediatric study that was included (Wang 1999) com-
pared isopropyl alcohol and saline in a population of 39 children
having elective outpatient surgery under general anesthesia. This
study found that while isopropyl alcohol did have an effect on
postoperative nausea at 20 minutes post-treatment (P = 0.05), this
effect could not be sustained at 60 minutes (RR 2.85, 95% CI
0.32 to 25.07, P = 0.35). No effect on postoperative vomiting was
demonstrated at 20 minutes or 60 minutes (RR 1.27, 95% CI
0.33 to 4.93).
Primary outcome: duration of nausea
Findings for studies measuring time to relief of nausea, which
could not be combined statistically, are presented in Table 1.
Primary outcome: severity of nausea
Studies measuring severity of nausea by nausea scale measure-
ments, which could not be combined statistically, are presented in
Table 2.
Secondary outcome: use of rescue anti-emetics
Four studies with a total of 215 participants compared isopropyl
alcohol to standard treatment (ondansetron or promethazine) and
reported the number of participants in each group who required
rescue anti-emetics. The studies by Cotton 2007, Merritt 2002,
Pellegrini 2009 and Winston 2003 were able to be combined in
a meta-analysis which showed a statistically significant effect (RR
0.66, 95% CI 0.45 to 0.98, P = 0.04) (Analysis 1.1). However,
due to the likely confounding of the study by Merritt 2002, from
the administration of preoperative prophylactic anti-emetics to
94 out of the 111 original participants, a sensitivity analysis was
performed. Without the Merritt data there was no statistically
significant evidence of an effect (RR 0.66, 95% CI 0.39 to 1.13, P
= 0.13) (Analysis 2.1). These findings are summarized in Summary
of findings for the main comparison.
Separating out results for participants with nausea only, as reported
inCotton 2007,Winston 2003 and Pellegrini 2009, we found that
the proportion requiring rescue anti-emetics was not significantly
different between the experimental and control groups (RR 0.66,
95% CI 0.39 to 1.13, P = 0.13) (Analysis 2.1).
Three studies of adult patients (Anderson 2004;Kamalipour 2002;
Langevin 1997), with a total of 135 participants, compared iso-
propyl alcohol and saline and measured the number of partici-
pants who required rescue anti-emetics. These studies were com-
bined. Meta-analysis showed a trend toward evidence of an effect
(RR 0.30, 95% CI 0.09 to 1.00, P = 0.05) (Analysis 4.1). These
findings are summarized in Summary of findings 2.
One study of 39 paediatric patients having day surgical proce-
dures (Wang 1999) also compared isopropyl alcohol and saline
and measured the number of participants requiring rescue anti-
emetics. For participants with nausea only, 60% of those in the
placebo (saline) group required rescue anti-emetics compared to
9% of those in the isopropyl alcohol group (RR 0.15, 95% CI
0.02 to 1.05). For participants with vomiting, 89% of the saline
group required rescue anti-emetics compared to 67% of the iso-
propyl alcohol group (RR 0.75, 95% CI 0.23 to 1.12).
One RCT (Anderson 2004) trialled a comparison of isopropyl al-
cohol, peppermint oil and saline inhalations. This study random-
ized 33 participants to receive either isopropyl alcohol, pepper-
mint oil or saline to treat reported nausea in a postoperative care
unit. Of the participants receiving isopropyl alcohol 45% required
rescue anti-emetics, while 60% of participants in the peppermint
oil group and 50% of the control (saline) group required rescue
anti-emetics. This study found no significant difference between
the treatment and control groups (no significance value reported).
Secondary outcome: adverse reactions
No data on adverse reactions to the experimental substances were
reported by any of the included studies.
Secondary outcome: patient satisfaction with treatment
Four studies measured patient satisfaction with treatment.
Cotton 2007 (comparing isopropyl alcohol to ondansetron) used
a four-point ordinal scale on which the participants were asked to
rate their postoperative experience as poor, fair, good or excellent;
participants in both the treatment and control groups reported
their experience as good or excellent, resulting in no statistically
significant difference between the groups (P > 0.05).
Winston 2003 also measured patient satisfaction using a four-
point ordinal scale (0 = poor; 1 = fair; 2 = good and 3 = ex-
cellent). For the ondansetron group: 0 = 1 participant (3%); 1
= 2 participants (6%); 2 = 17 participants (52%); and 3 = 13
participants (39%). For the isopropyl alcohol group, the satisfac-
tion numbers were: 0 = 0 participants; 1 = 0 participants; 2 = 18
participants (47%), and 3 = 20 participants (53%). The authors
stated that although these findings were not statistically signifi-
cant, they nonetheless regarded them as clinically significant (un-
reported data supplied via email). Results from Cotton 2007 and
Winston 2003 were collapsed into binary data (good or excellent
interpreted as satisfied) and combined in Analysis 5.1.
Patients also reported high levels of satisfaction with their treat-
ment regardless of allocation in Pellegrini 2009, with a median
score of 4 on a 5-point ordinal scale (1, totally dissatisfied; 2,
somewhat dissatisfied; 3, somewhat satisfied; 4, satisfied; 5, totally
satisfied).
Anderson 2004 measured patient satisfaction on a VAS (0 mm
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extremely dissatisfied, 100 mm fully satisfied). Participants across
all three groups reported high levels of satisfaction with their treat-
ment: isopropyl alcohol 90.3 (SD 14.9); peppermint oil 86.3 (SD
32.3); saline 83.7 (SD 25.6).
The results from all studies reporting on this outcome are collated
in Table 3.
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D I S C U S S I O N
Summary of main results
This review was able to include studies of isopropyl alcohol and
peppermint oil aromatherapy compared to a saline placebo, on-
dansetron, promethazine, or other unspecified ’standard anti-
emetic’ treatments. All aromatherapy was delivered via direct in-
halation. There were 311 adult and 91 paediatric patients in the
included studies. The majority of patients were women. Studies
were conducted in both inpatient and day surgery settings. Out-
comes measured were time to reduction in nausea, severity of nau-
sea, number of nausea and vomiting events, the use of ’rescue’ anti-
emetics, patient satisfaction, recurrence of symptoms, and cost of
treatment.
Isopropyl alcohol (IPA) has been tested in several studies, both
against standard pharmacological treatments and against other
aromatherapies and placebo, in both adults and children. In com-
parison to saline placebo, IPA appears effective in reducing the
number of patients requiring rescue anti-emetics (Kamalipour
2002; Langevin 1997) and in providing short-term relief of symp-
toms in children (Wang 1999). In two studies (Cotton 2007;
Winston 2003) IPA provided a faster time to 50% relief of symp-
toms than ondansetron and promethazine (Pellegrini 2009); how-
ever, when meta-analysed, there was no statistically significant dif-
ference in the number of participants requiring rescue anti-emet-
ics in the combined results of these three studies.
Peppermint oil inhalations are often recommended for PONV
(Chiravalle 2005; Pompeo 2007; Price 2007) however this review
was unable to find sufficient evidence to support this. Two stud-
ies examined the use of peppermint as a treatment for PONV
(Anderson 2004; Tate 1997) but only Anderson 2004 was ade-
quately randomized and blinded. Tate 1997 reported evidence of
an effect howevermethodological concerns mean that these results
should be viewed with caution. Anderson 2004 found that the
effect of peppermint oil inhalation was not statistically different
from the effect of inhalations of isopropyl alcohol or saline.
No adverse reactions were reported by any of the included studies.
Patient satisfaction with aromatherapy treatment appeared high
in studies that measured this outcome (Anderson 2004; Cotton
2007; Pellegrini 2009; Winston 2003), with patients reporting
high levels of satisfaction with their experience. However it should
be noted that all participants in these studies (treatment and com-
parison groups) reported high levels of satisfaction.
Overall completeness and applicability of
evidence
It seems likely that further studies of isopropyl alcohol to treat
postoperative nausea and vomiting could provide different results
from those described here. Well-conducted studies of peppermint
oil or other aromatherapiesmay provide definitive evidence for the
effectiveness of these therapies. The evidence base for aromather-
apy to treat PONV is currently incomplete, with only one study
of children meeting the inclusion criteria and many aromather-
apy treatments incompletely investigated or tested. While there
appears to be no evidence of adverse reactions from the use of
the included interventions, it is unclear from the included studies
whether data were collected on any possible adverse reactions ex-
perienced by participants. In the context of current postoperative
practice, there is a place for adjunct therapies to treat PONV and
while isopropyl alcohol vapour inhalation is a simple and inexpen-
sive treatment that seems to be more effective than placebo, there
is currently no evidence to suggest that it can replace pharmaco-
logical anti-emetics.
Of additional concern are the early time points utilised by all
included studies exceptTate 1997,which didmeasure PONVat 24
and 48 hours but only reported average daily scores for each group.
Apfel 2002 recommends that study authors measure PONV for
early (greater than two hours) and late (to 24 hours) outcomes.
The data able to be included in this review are incomplete for
effects longer than 60 minutes.
Due to the many risk factors for and influences on PONV, such
as type of anaesthesia, narcotic medication intake, sex, and type
of surgery, it was a concern that there were differences between
groups that might account for some of the effect. Examination of
the demographic and procedural data, however, shows that control
and experimental groups were very similar and that confounding
due to risk factors was unlikely.
It should be remembered that we have not included any evidence
of effectiveness for aromatherapy in the prevention of PONV and
that all results apply only to treatment of an existing complaint.
Quality of the evidence
The included studies were comprised of six RCTs and three CCTs,
with total of 402 participants. The overall quality of the retrieved
evidence was low, with incomplete reporting and unavailable data
hampering the comparison of most studies. Due to the age of sev-
eral studies, further data were either not available or the authors
were not contactable. The nine included studies measured the ef-
fectiveness of only two aromatherapy treatments for postoperative
nausea and vomiting, neither of which were shown to be effective
in comparison to standard pharmacological anti-emetics, although
isopropyl alcohol appears to be more effective than placebo.
Agreements and disagreements with other
studies or reviews
A recent systematic review of the effectiveness of noninvasive com-
plementary therapies for reducing PONV in women having ab-
dominal laparoscopic hysterectomy (Hewitt 2009) found, simi-
larly to this review, that there was no strong evidence to support
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the use of aromatherapy for PONV. We have been unable to find
any other systematic reviews of aromatherapy for treating PONV.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
From the evidence of this review, it seems that using isopropyl alco-
hol vapour inhalation as an adjunct therapy for PONV is unlikely
to be harmful and may reduce nausea for some adult patients. It
may provide a useful therapeutic option, particularly when the
alternative is no treatment at all. As an inexpensive, readily avail-
able therapy (in the form of injection site ’prep-pads’), isopropyl
alcohol vapour inhalation could be considered for use in situations
where standard pharmacological anti-emetics are unavailable, re-
fused by patients, or contra-indicated.
Included studies that examined this intervention used one prep-
pad or isopropyl alcohol-soaked cotton ball or gauze pad per treat-
ment and most asked the patient to take two or three deep breaths
while the pad was held close to their nose without touching. Treat-
ments were repeated up to three times without any adverse effects
being reported.
There is currently no evidence to show that using peppermint oil
aromatherapy reduces PONV, however there is no evidence of its
use being harmful.
Implications for research
It is important that future trials fully report their methodology,
demography and findings. Full descriptions of the results of in-
terventions would enable clinicians to make more informed de-
cisions about the uptake of these therapies in their clinical set-
ting. Improved reporting would also benefit future updates of this
review. There is an absence of large, well-reported trials in this
area, particularly of therapies other than isopropyl alcohol. Further
studies in paediatric populations are needed before aromatherapy
can be recommended for treatment of PONV in children. Future
trials should include measures for longer time intervals (two to 24
hours) and report discrete data on both postoperative nausea and
postoperative vomiting.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Anderson 2004
Methods Randomized controlled trial of peppermint oil, isopropyl alcohol or normal saline aro-
matherapy to treat postoperative nausea and vomiting
Setting: Postanaesthesia care unit (PACU) acute hospital, USA
Participants 33 patients aged 18 years+ having surgery under general or regional anaesthesia, or deep
IV sedation, who reported nausea in postanaesthesia care unit. Treatment groups did
not differ in the percentage having general anaesthesia, the type of surgery, age or gender
distribution
Exclusions: patients who were unable to give informed consent; patients who did not
require anaesthesia services
Interventions On the patient’s spontaneous report of postoperative nausea, they were instructed to take
three slow deep breaths to inhale the vapours from a pre-prepared gauze pad soaked with
either peppermint oil, isopropyl alcohol or normal saline placebo held directly under
their nostrils. After 2minutes the patient was asked to rate their nausea by VAS and given
the choice to continue aromatherapy or have standard IV anti-emetics. At 5 minutes
post the initial treatment, the patient was again asked to rate their nausea and if they
would like to continue aromatherapy or have standard IV anti-emetics
Outcomes 1. Severity of nausea as measured on 100 mm VAS at 2 minutes and 5 minutes after
treatment. Visual analogue scale from ’no nausea’ to ’worst possible nausea’
2. Choosing to use ’rescue’ anti-emetics.
3. Satisfaction with management of nausea, as measured by 100 mm VAS with range
from 0 = extremely dissatisfied to 100 = fully satisfied
Notes Possible lack of accuracy with some participants self-recording data in PACU if they had
poor or blurred vision. Authors Lynn Anderson and Dr Jeffrey Gross emailed to request
further information on group sizes, which was supplied by Dr Gross
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “group assignments were made in a ran-
domized, double-blind fashion”
Comment: probably done. Nurses admin-
istering treatment were unaware of con-
tents of each package of treatment mate-
rials. Patients who had consented to par-
ticipate entered study when they sponta-
neously reported nausea
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Anderson 2004 (Continued)
Allocation concealment (selection bias) Low risk “A random number generator determined
the contents of each serially numbered bag.
” “...prepared by an individual not other-
wise involved in the study...”
Data “analysed by investigator unaware of
treatment allocation”
Comment: probably done
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Staff administering treatment blinded by
use of “lightly scented” surgical masks.
However patients were self-reporting sub-
jective assessment of nausea and were not
blinded
Comment: Due to the strong aroma of
the peppermint oil, it would be impos-
sible to blind the patients receiving this
to their allocation once treatment com-
menced. Probably not done
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: outcomes reported for all par-
ticipants.
Selective reporting (reporting bias) Unclear risk Comment: results reported for all stated
outcomes, however original study protocol
not available
Other bias Low risk Comment: study appears to be free of other
sources of bias.
Cotton 2007
Methods Prospective randomized study of isopropyl alcohol inhalation as compared to IV on-
dansetron for PONV. Replication of study: Winston 2003.
Setting: PACU/same day surgery unit, USA.
Participants 100 women aged 18-65 who were scheduled for laparoscopic same-day surgery (ASA
physical status I, II or III)
Exclusions: patients who had recent upper respiratory tract infections, inability or im-
paired ability to breathe through the nose, or history of hypersensitivity to IPA, 5HT3
antagonists, promethazine or any other anaesthesia protocol medication, had used an
anti-emetic within 24 hours of surgery, were pregnant or breastfeeding, had history of
inner ear pathology, motion sickness or migraine headaches or were taking disulfram,
cefoperazone, or metronidazole
Interventions Comparison of inhaled isopropyl alcohol to intravenous ondansetron for treatment of
PONV
Ondansetron (control) group: nausea treatedwith ondansetron 4mg IV every 15minutes
to a maximum 8mg dose. Time, dose and VNRS score recorded
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Cotton 2007 (Continued)
IPA (experimental) group: nausea treated by holding a folded alcohol pad approximately
1/2 inch from the participant’s nares and instructing them to take 3 deep breaths in and
out through the nose. Treatments given every 5minutes up to a total of 3 administrations
Breakthrough PONV was treated with promethazine suppositories for both groups
Participants were also given supplies of IPA and promethazine to use as needed at home
after discharge and asked to record any occurrences of PONV with a data collection tool
provided by the researchers
Outcomes Time to reduction in nausea score as measured by Verbal Numeric Rating Scale (VRNS)
(range 0-10 where 0 = no nausea and 10 = worst imaginable nausea). Collected for
baseline at preop, then immediately postop in PACU and at any time the participant
complained of nausea. Additionally, participants who complained of nauseawere assessed
every 5 minutes following treatment for 30 minutes and then every 15 minutes until
discharge from PACU
Participants also reported data on PONV for the 24 hours post-discharge as well rating
their anaesthesia experience overall
Notes Author, Joseph Pellegrini contacted for further data. Some was provided however due to
data corruption problems not all requested data was available
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “patient was randomly assigned to the con-
trol group or the experimental group by
using a computer-generated random num-
bers program.”
Comment: done.
Allocation concealment (selection bias) Low risk “Block randomization was used for all of
the studies using a computer generated ran-
domization program done by an indepen-
dent party (myself ) who was not involved
in the data collection” (emailed author re-
sponse)
Comment: done.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Comment: no information given regard-
ing blinding. Does not appear to have been
done
Incomplete outcome data (attrition bias)
All outcomes
Low risk 28 participants “disenrolled due to proto-
col violations”: 12 from control group who
were given IPA postoperatively; 6 from ex-
perimental group given other anti-emetics
in PACU before IPA; and 10 who lost their
IPA or promethazine following discharge
to home
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Cotton 2007 (Continued)
Comment: probably done.
Selective reporting (reporting bias) Unclear risk Comment: original study protocol unavail-
able. Results reported for all stated out-
comes
Other bias Low risk Comment: study appears to be free of other
sources of bias.
Kamalipour 2002
Methods Randomized controlled trial of ISO versus normal saline placebo for treatment of PONV
Setting: postoperative care unit, acute hospital, Iran.
Participants 82 consecutive patients randomized into experimental and control groups. No age data
or demographic except 48 female/34 male
Interventions 2 sniffs of ISO (treatment) or 2 sniffs normal saline (control) (on reporting symptoms)
and re-treated at 5 minutes if necessary. Patients who did not respond the 2nd time
received metoclopramide injection
Outcomes Response to treatment/cessation of symptoms, recurrence of symptoms, use of rescue
anti-emetics
Notes Attempted to contact author, Dr H Kamalipour, via email however no response received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The patients were randomly divided into
two groups.”
Comment: probably done.
Allocation concealment (selection bias) Unclear risk Comment: no data.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Comment: no data.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: data reported for all stated out-
comes.
Selective reporting (reporting bias) Unclear risk Comment: brief report with little detail.
Other bias Unclear risk Comment: unable to ascertain from details
reported.
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Langevin 1997
Methods Double-blinded cross-over clinical trial/pilot study.
Setting: acute hospital, USA.
Participants 15 consecutive patients in PACU who complained of nausea or vomiting after elective
surgery
Interventions Either 0.5 ml saline or 0.5 ml isopropyl alcohol on a cotton ball (according to random
sequence) was held under participants’ noses and the participant was instructed to sniff
twice. If symptoms recurred, the test agents were re-administered in random sequence.
When neither test agent was effective, standard anti-emetics were given and the PONV
assessed every 5 minutes until participant left PACU
Outcomes Severity of PONV as assessed with VAS. VAS range from 0 = none to 10 = vomiting
Treatment failure attributed to the last agent given.
Notes No demographic data supplied in brief report. Letter sent to author, Dr Paul Langevin,
to ask for more data, no response received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “the test agents were readministered in the
randomized sequence”
Comment: no information on how this se-
quence was generated.
Allocation concealment (selection bias) Unclear risk Comment: no information reported on
who conducted the allocation and how
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “We designed a randomized double-
blinded study...” “Nurses who adminis-
tered the test therapywere blinded to group
assignment by applying an ISO-soaked
Band-Aid under their noses while another
person applied the test agent to a cotton
ball, which was attached to a sponge stick.
”
Comment: participants would not have
been blinded to the treatment due to the
distinctive odour of the isopropyl alcohol.
Unclear where the ’double-blinding’ oc-
curred
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: original study protocol not
available.
Selective reporting (reporting bias) Low risk Comment: data reported for all partici-
pants, no apparent losses to follow-up
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Langevin 1997 (Continued)
Other bias Unclear risk Comment: minimal data reported in this
publication.
Merritt 2002
Methods Controlled clinical trial of isopropyl alcohol inhalation for treatment of PONV
Setting: acute hospital, USA.
Participants 111 adults having surgery (40 with nausea were evaluated for study). Age range: 19-80
years; mean age = 43. Types of surgery included intra-abdominal (29.7%), orthopaedic/
extremity (23.4%), perineal (19.8%) neuro-skeletal (10.8%), extra-thoracic (6.3%) eyes/
ears/nose/throat (6.3%), neck (3.6%)
Of 40 patients evaluated for study, 21 received IPA and 18 were controls. 1 patient
entered into the study had their PONV resolve spontaneously
Inclusion criteria were (a) requirements for general anaesthesia, (b) ability to breathe
through nose before and after procedure, (c) minimum of 18 years of age, (d) American
Society of Anesthesiologists (ASA) physical status of I, II, or III, and (e) ability to read
and write English
Exclusion criteria were (a) allergy to IPA, (b) alcohol abuse, (c) no recent history of nausea
or vomiting within the last 8 hours, (d) no recent intake of cefoperazone, Antabuse, or
metronidazole, (e) ability to communicate in recovery room, (f ) regional anaesthesia,
and (g) monitored anaesthesia care.
Interventions Isopropyl alcohol inhalation for treatment of PONV. “If nausea or vomiting was present
in control participants, an appropriate anti-emetic was given. Experimental participants
were given IPA via nasal inhalation using standard hospital alcohol pads. The participant
was instructed to take three deep sniffs with the pad one inch from the nose. This was
repeated every five minutes for three doses or until nausea and vomiting was relieved. If
nausea and vomiting continued after three doses of IPA, then an intravenous drug was
given.”
Outcomes Severity of PONV as measured by a descriptive ordinal scale (DOS) from “0 to 10, with
0 being no nausea or vomiting and 10 being the worst nausea and vomiting they could
imagine.”
Cost of treatment in USD.
Notes Anti-emetic prophylaxis was given to patients in both groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Group assignment was alternated by day:
experimental one day and control the next.
”
Comment: study is controlled clinical trial.
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Merritt 2002 (Continued)
Allocation concealment (selection bias) Unclear risk Comment: allocators and caregivers appear
to have been aware of the allocation
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Participants were blinded to which treat-
ment they were to receive.”
Comment: probably done.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: original study protocol unavail-
able. Stated outcomes were all addressed in
report
Selective reporting (reporting bias) Unclear risk Comment: no apparent loss to follow-up.
No P values reported for main findings of
pre and post-test DOS, though P value for
cost differences reported
Other bias Unclear risk “Only 40 of the 111 participants recruited
had PONV. This is explained by aggres-
sive prophylactic treatment at the study fa-
cility where only 7 (6.3%) of 111 partici-
pants did not receive prophylactic medica-
tion and none of these 7 participants had
PONV.Additionally, the researchers specu-
late that painmay have been a confounding
factor in accurate assessment on the DOS.
”
Comment: several possible confounders.
Pellegrini 2009
Methods Randomized controlled trial comparing 70% isopropyl alcohol inhalation to promet-
hazine to treat breakthrough nausea in surgical patients at high risk of PONV
Setting: day hospital, USA.
Participants 85 surgical patients scheduled for general anaesthesia of more than 60 minutes’ duration
and having 2 of the 4 individual risk
factors for PONV, (female gender, nonsmoker, history of PONV or motion sickness)
(IPA group, 42; promethazine group, 43)
Excluded: recent upper respiratory infection; documented allergy to IPA, ondansetron,
promethazine, ormetoclopramide; anti-emetic or psychoactive drug use within 24 hours;
inability to breathe through the nose; pregnancy; history of inner ear pathology; and/or
taking disulfiram, cefoperazone, or metronidazole
Interventions Control group: 12.5 to 25 mg IV promethazine for complaints of PONV in the
postanaesthesia care unit (PACU) and same-day surgery unit (SDSU) and by promet-
hazine suppository self-administration following discharge to home
Experimental group: administration of inhaled 70% IPA.
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Pellegrini 2009 (Continued)
Outcomes Nausea, measured by Verbal Numeric Rating Scale (VNRS) (0-10, 0 = no nausea 10 =
worst imaginable nausea)
Incidence of nausea events in PACU, SDSU or at home (number)
Doses of promethazine required as rescue anti-emetic (number)
Promethazine requirements in PACU, SDSU or at home (mg).
Time in minutes to 50% reduction of nausea scores.
Participant satisfaction.
Notes All participants received anti-emetic prophylaxis prior to surgery. Author J Pellegrini
emailed to request numeric data for results published in graph form. Data received.
Other clarifications requested and some were received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “All subjects were then randomly assigned
using a computer-generated random num-
bers process into a control or an experimen-
tal group.”
Comment: probably done.
Allocation concealment (selection bias) Low risk “Block randomization was used for all of
the studies using a computer generated ran-
domization program done by an indepen-
dent party (myself ) who was not involved
in the data collection.” (emailed author re-
sponse)
Comment: probably done.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Comment: no data on blinding. It appears
that participants and assessors were aware
of group allocations during study
Incomplete outcome data (attrition bias)
All outcomes
Low risk “A total of 96 subjects were enrolled, but
11 subjects were withdrawn, leaving a to-
tal of 85 subjects (IPA group, 42; promet-
hazine group, 43) whose data would be in-
cluded in the final analysis. Reasons for
withdrawal included 4 subjects who re-
ceived additional anti-emetics intraopera-
tively (2 in each group), 1 subject inadver-
tently enrolled despite being scheduled for
a nasal surgical procedure (IPA group), and
6 subjectswho required postoperative inpa-
tient hospitalization for reasons unrelated
to PONV (3 in each group).”
Comment: probably done.
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Pellegrini 2009 (Continued)
Selective reporting (reporting bias) Unclear risk Comment: all outcomes stated in the article
have data reported, however original study
protocol is not available
Other bias Low risk Comment: no other sources of bias appar-
ent.
Tate 1997
Methods Three-arm controlled clinical trial of peppermint oil inhalations, peppermint essence
inhalations (placebo) and no treatment (control) to treat PONV in women
Setting: acute hospital, UK.
Participants 18womenundergoingmajor gynaecological surgery.Meanweight group 1: 152lb; group
2: 139.5lb; group 3: 144.2lb. Mean height group 1: 64.2in; group 2: 62.5in; group 3:
64.3in. Mean age group 1: 54 years; group 2: 43.2 years; group 3: 45.5 years. Participants
were assessed as having no significant differences in personal characteristics, past medical
history or preoperative anxiety levels. There were no statistically significant differences in
preoperative fasting times, anaesthetic and recovery times or postoperative fasting times.
Five of the experimental group had intra-abdominal surgery, compared with three in
each of the other two groups
Interventions Participants were given bottles of their assigned substance postoperatively and instructed
to inhale the vapours from the bottle whenever they felt nauseous
Outcomes Self-reported nausea as measured by VAS of 0-4 where 0 = “not experiencing any nausea”
and 4 = “about to vomit” reported as the average score per person per day
Cost of treatment in GBP.
Patient satisfaction with treatment, reported narratively.
Notes Participants may or may not have received standard anti-emetics in PACU. Author
Sylvina Tate supplied some extra data on group allocation methods
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The subjects were assigned to one of three
groups.”
Comment: author states that participants
were “randomly assigned” to ward areas
Allocation concealment (selection bias) Unclear risk Comment: no information reported re-
garding concealment.
Blinding (performance bias and detection
bias)
Low risk Comment: use of peppermint essence as
placebo blinded experimental and placebo
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Tate 1997 (Continued)
All outcomes group patients to treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no mention of patients lost to
follow-up, however group numbers are not
reported. (Group numbers clarified by au-
thor via email)
Selective reporting (reporting bias) High risk Comment: trialists did not provide mea-
sure of statistical significance or measures
of variance for daily average nausea scores,
even though they state ’statistically signif-
icant difference in the amount of self-re-
ported nausea between the placebo and ex-
perimental groups
Other bias Unclear risk Comment: due to study design, entirely
possible there was some demand-charac-
teristic effect on patient self-reporting of
results. However, experimental group re-
ceived ’on average, slightly less’ postoper-
ative anti-emetics and more postoperative
opioids than placebo group, which would
tend to indicate evidence of an effect
Wang 1999
Methods Double-blind randomized controlled study of isopropyl alcohol as a treatment for PONV.
“When any episode of vomiting or nausea occurred, patients were randomized, using a
random number table to receive a cotton ball soaked with ISO or saline placed under the
patient’s nose by the nursing staff. The patient was instructed to sniff twice by a nurse
who was blind to group assignment. It should be emphasized that the nursing staffs were
instructed not to smell the content of cotton ball and to hold it away from themselves
when administering to patient
If the severity of nausea or vomiting improved after a single treatment, a VAS assess-
ment of nausea was obtained every 5 minutes until the patient was discharged or PONV
symptoms recurred. Improvement of nausea was defined as a decrease of at least 40%
in initial VAS score, and improvement of vomiting was defined as no further episodes
of vomiting. If, after treatment, severity of nausea did not improve or retching/vomit-
ing persisted, a second treatment with the same agent was given. Treatment sequences
were repeated for a maximum of three times in a 15-minute period. When severity of
either nausea or vomiting failed to improve despite three treatments, intravenous (IV)
ondansetron 0.1 mg/kg (maximum 4 mg) was administered. If symptoms persisted, a
second dose of ondansetron was administered. For patients who failed to improved after
two ondansetron doses (maximum dose: 8mg), other IV ant-emetic medications (i.e.,
200 mg/kg of metoclopramide; 10 mg/kg droperidol) were given.”
Setting: acute paediatric day surgery centre.
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Wang 1999 (Continued)
Participants 91 children aged 6-16 years having surgery under general anaesthesia. ASA physical status
I and II. Of these, 39 developed PONV and were enrolled into treatment or control
groups. Treament n = 20. Control n = 19. No significant differences in demographic
data across groups
Exclusions: children with a history of chronic illness or developmental delay
Interventions Inhalations of isopropyl alcohol or saline placebo. Intervention repeated up to three
times. IV ondansetron was used as ’rescue therapy’ if PONV continued
Outcomes 1. Severity of nausea and vomiting as measured by 100 mm VAS with a range of 0 = no
nausea to 100 = extreme nausea
2. Use of rescue anti-emetics as measured by drug and number of doses
Notes Study author, Dr Shu-Ming Wang contacted for any further data, however due to the
age of the study there was none available
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “If any episode of vomiting or nausea oc-
curred, patients were randomized, using a
random number table to receive a cotton
ball soaked with ISOor saline placed under
the patient’s nose by the nursing staff.”
Comment: probably done.
Allocation concealment (selection bias) Unclear risk Comment: no data on who conducted the
allocation and any degree of separation
from the conduct of the study
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The patient was instructed to sniff twice
by a nurse who was blind to group assign-
ment. It should be emphasized that the
nursing staffs were instructed not to smell
the content of cotton ball and to hold it
away from themselves when administering
to patient.”
Comment: probably done.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: data reported for all partici-
pants. No apparent losses to follow-up
Selective reporting (reporting bias) Unclear risk Comment: original study protocol not
available. All stated outcomes reported
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Wang 1999 (Continued)
Other bias Low risk Comment: no other sources of bias appar-
ent.
Winston 2003
Methods Randomized controlled trial of isopropyl alcohol for treatment of PONV. Participants
were randomized to receive either isopropyl alcohol inhalations, or 4mg ondansetron
Setting: same day surgery centre, USA.
Participants 100 women aged 18-65 years who were scheduled for diagnostic laparoscopy, operative
laparoscopy or laparoscopic bilateral tubal occlusion (ASA physical status I, II or III) in
a day surgery unit
Exclusions: inability or impaired ability to breathe through the nose, or history of sensi-
tivity to IPA or ondansetron, had used an anti-emetic within 24 hours of surgery, preg-
nant or breastfeeding, reported existing nausea, history of significant PONV resistant to
anti-emetics, using disulfram or had a history of alcoholism
Interventions Comparison of inhaled 70% isopropyl alcohol to ondansetron for treatment of PONV
Ondansetron (control) group: at first request for treatment participants in this group
received IV ondansetron 4mg, repeated once in 15 minutes if required
70% IPA (experimental) group: a standard alcohol prep pad was held under the partici-
pant’s nose and she was instructed to take 3 consecutive deep breaths through the nose
Nausea score collected for baseline at preop, then immediately postop inPACUand at any
time the participant complained of nausea. Additionally, participants who complained
of nausea were assessed every 5 minutes following treatment for 30 minutes and then
every 15 minutes until discharge from PACU
Outcomes 1. Nausea score as measured by Verbal Numeric Rating Scale (VRNS) (range 0-10 where
0 = no nausea and 10 = worst imaginable nausea)
2. Number of emetic events, defined as episodes of nausea or vomiting more than one
minute apart
3. Time to reduction of PONV in minutes.
4. Cost.
5. Patient satisfaction with anaesthesia care.
Notes This study was replicated by Cotton 2007 with the number and frequency of IPA
inhalations increased. Author J Pellegrini provided additional data via email
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “subjects were randomly assigned to receive
inhaled 70% IPA (experimental group) or
IV ondansetron (control group) for the
treatment of PON” “despite the use of
block randomization”
Comment: author states via email that ran-
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Winston 2003 (Continued)
domization was conducted using a com-
puter generated random numbers table
Allocation concealment (selection bias) Low risk “Block randomization was used for all of
the studies using a computer generated ran-
domization program done by an indepen-
dent party (myself ) who was not involved
in the data collection.”
Comment: probably done.
Blinding (performance bias and detection
bias)
All outcomes
High risk “...this did not allow us to blind the study
intervention.”
Comment: it appears that no blinding of
participants or caregivers was done
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: it appears that data was re-
ported for all participants, no evidence of
exclusions or attrition
Selective reporting (reporting bias) Unclear risk Comment: original study protocol unavail-
able. Despite stating collection of data on
patient satisfaction with anaesthetic experi-
ence, no results for this were reported, how-
ever this data was made available by an au-
thor via email
Other bias Low risk Comment: no other sources of bias appar-
ent.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Apariman 2006 Prevention of PONV, not treatment.
Apfel 2001 Not RCT/CCT. Not aromatherapy.
Arfeen 1995 Prevention of PONV, not treatment.
Betz 2005 Not RCT/CCT.
Bone 1990 Prevention of PONV, not treatment.
Buckle 1999 Not RCT/CCT.
Chaiyakunapruk 2006 Prevention of PONV, not treatment.
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Chiravalle 2005 Not RCT/CCT.
Chrubasik 2005 Not RCT/CCT.
Couture 2006 Prevention of PONV, not treatment.
DePradier 2006 Not RCT/CCT.
Eberhart 2003 Prevention of PONV, not treatment.
Eberhart 2006 Not RCT/CCT.
Ekenberg 2007 Not RCT/CCT.
Ernst 2000 Not RCT/CCT.
Fujii 2008 Not RCT/CCT.
Geiger 2005 Not RCT/CCT.
Golembiewski 2005 Not RCT/CCT.
Keifer 2007 Not RCT/CCT.
Kim 2006 Not PONV.
Kim 2007 Not PONV.
King 2009 Not RCT/CCT.
Koretz 2004 Not RCT/CCT.
Mamaril 2006 Not RCT/CCT.
Morin 2004 Not RCT/CCT.
Nale 2007 Prevention of PONV, not treatment.
Nanthakomon 2006 Prevention of PONV, not treatment.
Phillips 1993 Prevention of PONV, not treatment.
Pompeo 2007 Not RCT/CCT.
Pongrojpaw 2003 Prevention of PONV, not treatment.
Rosén 2006 Not RCT/CCT.
Spencer 2004 Not RCT/CCT.
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Tavlan 2006 Prevention of PONV, not treatment.
Tramer 2001 Not RCT/CCT.
Visaylaputra 1998 Prevention of PONV, not treatment.
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D A T A A N D A N A L Y S E S
Comparison 1. Isopropyl alcohol versus standard treatment for PONV
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion requiring rescue anti-
emetics
4 215 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.45, 0.98]
Comparison 2. Isopropyl alcohol versus standard treatment for PON: sensitivity analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion requiring rescue anti-
emetics
3 176 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.39, 1.13]
Comparison 3. Isopropyl alcohol versus standard treatment for PON
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion requiring rescue anti-
emetics
3 176 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.39, 1.13]
Comparison 4. Isopropyl alcohol versus saline
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion requiring rescue anti-
emetics
3 135 Risk Ratio (M-H, Random, 95% CI) 0.30 [0.09, 1.00]
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Comparison 5. Aromatherapy versus standard anti-emetics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient satisfaction 2 172 Risk Ratio (M-H, Random, 95% CI) 1.12 [0.62, 2.03]
A D D I T I O N A L T A B L E S
Table 1. Table 1. Studies measuring time to relief of nausea
Study Design Intervention/Control Outcome Findings
Cotton 2007 RCT IPA/ondansetron Time to 50% reduction in nausea
(VNRS1)
IPA: mean 15.00 (SD:10.6mins)
Ondansetron: mean 33.88 (SD: 23.
2mins)
Kamalipour 2002 RCT IPA/saline Percentage “response”2 to treatment
within 5 minutes
IPA: 78%
Saline: 7.3%
Langevin 1997 CCT IPA/saline Percent with complete relief of nau-
sea in 5 minutes
IPA: 80%
Saline: 0%
Pellegrini 2009 RCT IPA/Promethazine Mean time to 50% reduction in nau-
sea scores (VNRS1)
IPA: (mean +/- SD)
PACU3: 6.43 +/- 3.78 minutes
SDSU4: 8.33 +/- 4.82 minutes
HOME5: 16.58 +/- 6.9 minutes
Promethazine: (mean +/- SD)
PACU3: 20.5 +/- 18.236 minutes
SDSU4: 23.3 +/- 18.86 minutes
HOME5: 26.67 +/- 12.5 minutes
Winston 2003 RCT IPA/ondansetron Mean time to 50% reduction of
VNRS1
IPA: 6.3 minutes
Ondansetron:
27.7 minutes
1VRNS: Verbal Numeric Rating Scale.
2Meaning of response not defined by study authors.
3PACU: Postanaesthesia Care Unit.
4SDSU: Same Day Surgery Unit.
5Home: Participant’s residence post-discharge.
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Table 2. Table 2. Studies measuring a decrease in nausea scores
Study Design Intervention/Control Outcome Findings
Merritt 2002 CCT IPA/standard anti-emetics Decrease in mean nausea score
(DOS1) 0-10 (0 = no nausea, 10 =
worst nausea and vomiting imag-
inable)
IPA: Mean DOS1 score Pre-treat-
ment: 5.71 Post-treatment: 2.7
Standard treatment: Pre-treat-
ment: 6.11 Post-treatment: 1.94
Tate 1997 CCT Peppermint oil/peppermint
essence/standard treatment
Mean daily nausea scores (DOS1)
0-4 (0 = no nausea, 4 = about to
vomit)
Standard treatment: mean daily
nausea score = 0.975
Peppermint essence mean daily
nausea score (placebo): 1.61
Peppermint oil mean daily nausea
score: 0.5
Wang 1999 RCT IPA/saline Percentage of participants with
decrease in nausea after 3 treat-
ments (VAS) 0-100 (0 = no nau-
sea, 100 = extreme nausea)
IPA: 91%
Saline: 40%
1DOS: Descriptive Ordinal Scale.
Table 3. Patient satisfaction
Study Design Intervention/Comparison Measure Satisfied
Cotton 2007 RCT IPA/ondansetron 4-point DOS
(poor, fair, good, excellent)
Good or excellent: Intervention:
38/38
Comparison: 34/34
Winston 2003 RCT IPA/ondansetron 4-point DOS
(poor, fair, good, excellent)
Good or excellent:
Intervention: 38/50
Comparison: 30/50
Pellegrini 2009 RCT IPA/Promethazine 5-point DOS
(1 = totally unsatisfied, 5 = totally
satisfied)
Both groups report median score 4
Anderson 2004 RCT IPA/Saline/Peppermint 100mm VAS (0 mm extremely dis-
satisfied; 100 mm fully satisfied)
IPA: 90.3 (SD: 14.9)
peppermint: 86.3 (SD: 32.3)
saline: 83.7 (SD: 25.6)
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The original protocol stated “We will judge the study quality using a validated critical appraisal checklist developed by the Joanna
Briggs Institute and based on the work of The Cochrane Collaboration and the Centre for Reviews and Dissemination (Figure 2). This
checklist assesses selection, allocation, treatment, and attrition biases”. Due to changes in the Cochrane requirements, we have used the
Cochrane risk of bias assessment instead.
We had originally planned to search the website http://www.nhmrc.gov.au/nics/asp/index.asp, however this no longer exists and http:/
/www.nhmrc.gov.au/nics/index.htm was searched instead.
I N D E X T E R M S
Medical Subject Headings (MeSH)
2-Propanol [∗administration & dosage]; Administration, Inhalation; Antiemetics [∗administration & dosage]; Aromatherapy
[∗methods]; Controlled Clinical Trials as Topic; Plant Oils [∗administration & dosage]; Postoperative Nausea and Vomiting [∗therapy];
Salvage Therapy [methods]
MeSH check words
Humans
42Aromatherapy for treatment of postoperative nausea and vomiting (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
